http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015212280-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b70f25a6aa51236e53b78a767f47a154
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0066
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
filingDate 2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520630edea19aca02502685f22410656
publicationDate 2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2015212280-A
titleOfInvention Gel-forming agent comprising sulfa drug and chitosan drug, the dosage form being powder
abstract The present invention provides a gel-forming agent having a marked therapeutic effect compared to conventional sulfa drugs and chitosan agents alone, particularly a gel-forming agent for protecting a body fluid leakage affected area, and a gel-forming agent for treating a wound. A gel-forming agent comprising a sulfa drug and a chitosan drug, the dosage form being a powder. Moreover, the method including the process of applying the kit and gel formation agent containing a gel formation agent. A gel-forming agent that exhibits an antibacterial action of a sulfa drug by applying a combination of a sulfa drug and a chitosan agent that are powders in a range where the affected area pH is more therapeutically effective. In addition, the wet environment of the affected area is maintained appropriately, the granulation is properly formed, and the powder is formed, so that the treatment person sprays the gel forming agent without directly touching the affected area by using an appropriate powder container. Of applying a gel-forming agent. [Selection figure] None
priorityDate 2013-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409702108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425183462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457193577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450961383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426384952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414858434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580873
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411621213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5323
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21252321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079160

Total number of triples: 79.